Table: Brightpath Biotherapeutics -2018/19 parent forecast

BrightPath Biotherapeutics Co

15/03/2019 06:00

Mar 15 (Reuters) -
              Brightpath Biotherapeutics Co., Ltd.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2019      Mar 31, 2019   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           150 mln                       
  Operating      loss 2.20                      
  Recurring      loss 2.20                      
  Net            loss 2.20                      
  EPS         loss 52.59 yen                    
 
  NOTE - Brightpath Biotherapeutics Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T